Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 14

Results For "rating"

2025 News Found

KIMS Hospitals launches Institute of Advanced Neurosciences in Bengaluru
Hospitals | May 04, 2026

KIMS Hospitals launches Institute of Advanced Neurosciences in Bengaluru

New Centre of Excellence at Electronic City campus to offer specialised care in epilepsy, cerebrovascular disorders, neurointervention, skull base and spine surgery


Fertin Pharma appoints Aditya Sharma as Managing Director for India operations
People | May 04, 2026

Fertin Pharma appoints Aditya Sharma as Managing Director for India operations

Healthcare and consumer wellness leader brings extensive experience in business transformation, commercial strategy and growth leadership to Fertin India


Karunanithi Ponnusamy elevated to President – Animal Health Business at Alembic Pharma
People | May 04, 2026

Karunanithi Ponnusamy elevated to President – Animal Health Business at Alembic Pharma

With over 30 years of pharmaceutical industry experience, Ponnusamy will lead Alembic’s animal health business strategy, market expansion, and operational growth initiatives


KIMS Hospitals launches Advanced Neurosciences Institute in Bengaluru
Healthcare | May 04, 2026

KIMS Hospitals launches Advanced Neurosciences Institute in Bengaluru

The newly established institute is equipped with advanced infrastructure designed to integrate multiple specialties under one roof


HealthFab raises Rs 20 crore in Series A funding from Atomic Capital
Startup | May 04, 2026

HealthFab raises Rs 20 crore in Series A funding from Atomic Capital

Funds to support product expansion, quick commerce growth, and manufacturing scale-up for holistic period care solutions


ten23 health successfully tests West Synchrony S1 PFS system on fill-finish lines
News | May 04, 2026

ten23 health successfully tests West Synchrony S1 PFS system on fill-finish lines

Early implementation of West Synchrony S1 platform aims to accelerate biologics and vaccine development while reducing manufacturing risk for biopharma partners


FDA advisory panel backs AstraZeneca prostate cancer combo in decisive vote
News | May 04, 2026

FDA advisory panel backs AstraZeneca prostate cancer combo in decisive vote

The Committee backed the combination based on results from the CAPItello-281 Phase III trial, marking a key milestone in the regulatory pathway for AstraZeneca’s targeted therapy strategy in prostate cancer


Bristol Myers Squibb begins 2026 with growth momentum
News | May 04, 2026

Bristol Myers Squibb begins 2026 with growth momentum

The company’s Growth Portfolio delivered $6.2 billion in revenue


IMCD posts steady Q1 2026 performance with €130 million EBITA amid global uncertainty
Supply Chain | May 02, 2026

IMCD posts steady Q1 2026 performance with €130 million EBITA amid global uncertainty

The company posted revenue of €1,267 million, up 6% on a constant currency basis


Thermo Fisher opens flagship US Bioprocess Design Center in Massachusetts
R&D | May 02, 2026

Thermo Fisher opens flagship US Bioprocess Design Center in Massachusetts

The 4,000-square-foot facility is designed as a hands-on hub where customers can work directly with scientists and engineers